Gene therapy of Retinal Diseases


Gene therapy is growing potentially in the field of ophthalmology having mailnly three characteristics- convenience in terms of injections and eye surgery, tight blood-ocular barriers which save other organ from contamination, its immune-privileged status facilitating the accommodation to the antigenicity of a viral vector.


  • Adeno-associated Viral Gene Therapy
  • Laser Congenital Amaurosis
  • Usher’s Syndrome

Related Conference of Gene therapy of Retinal Diseases

September 14-15, 2026

40th European Ophthalmology Congress

Rome, Italy
September 14-15, 2026

7th World Congress on Ophthalmology and Vision Science

Rome, Italy
September 14-15, 2026

6th European Congress on Laser, Optics and Photonics

Barcelona, Spain
September 21-22, 2026

21st International Conference on Ophthalmology and Vision Science

Amsterdam, Netherlands
October 05-06, 2026

26th Global Ophthalmologists Annual Meeting

Rome, Italy
October 15-16, 2026

8th International Conference on Optometry

Paris, France
December 03-04, 2026

9th International Eye and Vision Congress

Madrid, Spain